Evidence map›Paper›PMID 33936203›Full record

ArticleJournal of oncology2021

MCT4 Promotes Tumor Malignancy in F98 Glioma Cells.

Anna Maria Reuss, Dominik Groos, Ali Ghoochani, Michael Buchfelder, Nicolai Savaskan

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 18 citations in OpenAlex.

  1. Methylglyoxal AttenuatesInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. The role of lactate in cardiovascular diseases.Cell communication and signaling : CCS · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anna Maria ReussLaboratory for Translational Cell Biology & Neurooncology, Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), 91054 Erlangen, Germany.ORCID https://orcid.org/0000-0003-1096-3030
Dominik GroosInstitute of Physiology and Pathophysiology, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), 91054 Erlangen, Germany.ORCID https://orcid.org/0000-0002-1178-1354
Ali GhoochaniLaboratory for Translational Cell Biology & Neurooncology, Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), 91054 Erlangen, Germany.ORCID https://orcid.org/0000-0002-5352-0072
Michael BuchfelderLaboratory for Translational Cell Biology & Neurooncology, Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), 91054 Erlangen, Germany.ORCID https://orcid.org/0000-0002-1955-4957
Nicolai SavaskanLaboratory for Translational Cell Biology & Neurooncology, Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), 91054 Erlangen, Germany.ORCID https://orcid.org/0000-0003-1348-094X
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monocarboxylate transporter 4 (MCT4,

Identifiers

PMID33936203
PMCPMC8060090
OpenAlexW3156904957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.